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Abstract
Objective. To propose simple capillaroscopic definitions for interpretation of capillaroscopic morphologies
and to assess inter-rater reliability.
Methods. The simple definitions proposed were: normal—hairpin, tortuous or crossing; abnormal—not
hairpin, not tortuous and not crossing; not evaluable—whenever rater undecided between normal and
abnormal. Based upon an aimed kappa of 0.80 and default prevalences of normal (0.4), abnormal (0.4)
and not evaluable (0.2) capillaries, 90 single capillaries were presented to three groups of raters: experi-
enced independent raters, n = 5; attendees of the sixth EULAR capillaroscopy course, n = 34; novices after
a 1-h course, n = 11. Inter-rater agreement was assessed by calculation of proportion of agreement and by
kappa coefficients.
Results. Mean kappa based on 90 capillaries was 0.47 (95% CI: 0.39, 0.54) for expert raters, 0.40 (95%
CI: 0.36, 0.44) for attendees and 0.46 (95% CI: 0.41, 0.52) for novices, with overall agreements of 67%
(95% CI: 63, 71), 63% (95% CI: 60, 65) and 67% (95% CI: 63, 70), respectively. Comparing only normal vs
the combined groups of abnormal and not evaluable capillaries did increase the kappa: 0.51 (95% CI:
0.37, 0.65), 0.53 (95% CI: 0.49, 0.58) and 0.55 (95% CI: 0.49, 0.62). On the condition that the capillaries
were classifiable, the mean kappa was 0.62 (95% CI: 0.50, 0.74) for expert raters (n = 65), 0.76 (95% CI:
0.69, 0.83) for attendees (n = 20) and 0.81 (95% CI: 0.74, 0.89) for novices (n = 44).
Conclusion. This multicentre, international study showed moderate reliability of simple capillaroscopic
definitions for describing morphology of capillaries by rheumatologists with varying levels of expertise.
Novices were capable of distinguishing normal from abnormal capillaries by means of a 1-h training
session. In future studies, the class not evaluable may be obsolete.
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Rheumatology key messages
. The EULAR study group on microcirculation aims to standardize morphological interpretation of individual
capillaries.
. Novices in capillaroscopic evaluation can distinguish normal from abnormal capillaries by means of a 1-h training
session.
. Multicentre, international evaluation of proposed simple capillaroscopic definitions shows moderate reliability for
describing capillary morphology in rheumatic diseases.
Introduction
The EULAR study group on microcirculation in rheum-
atic diseases (RDs), established in 2014, aims to build
an international network of centres of excellence to fa-
cilitate collaboration and the exchange of knowledge
within Europe. Its aims are, among others: to study
microvascular mechanisms involved in the progression
of RD, to develop natural history investigations operat-
ing across existing cohorts of European centres and to
identify models based on microvascular assessment
tools to predict disease progression and outcome
of RD. At present, the current literature contains a var-
iety of definitions concerning the morphology of individ-
ual capillaries [13]. Additionally, not all single
capillaroscopic morphologies have been credited with
the same inter-rater reliability [4]. Owing to this short-
coming, standardization of morphological interpretation
and simplification of morphological nomenclature
seems necessary. Subsequently, one of the first tasks
of the EULAR study group on microcirculation was to
propose simple capillaroscopic definitions for interpret-
ation of single capillaroscopic morphologies and
assess their inter-rater reliability, as described in the
present report.
Patients and methods
Collecting of capillaroscopic images
The first step was to gather a set of images that would
include a broad spectrum of nailfold capillary abnormalities.
Images were, therefore, acquired from 12 subjects, judged
by one observer expert in nailfold videocapillaroscopy
(V.S., Ghent): seven patients with a scleroderma pattern
(three patients with the limited cutaneous form of systemic
sclerosis, two patients with the diffuse cutaneous form of
systemic sclerosis and two patients with a limited systemic
sclerosis, according to LeRoy and Medsger’s classifica-
tion), two patients with SLE, one patient with MCTD, one
patient with UCTD and one healthy control, according to
currently used classification criteria [2, 510]. The nailfolds
of the second, third, fourth and fifth fingers had been exam-
ined bilaterally in each patient using an optical probe video-
capillaroscope equipped with a200 magnification contact
lens and connected to image analysis software (Videocap;
DS MediGroup). Four adjacent fields, extending over 1 mm
in the middle of the nailfold, had been stored per finger [4].
The images were made anonymous before being assessed
by the raters.
Marking of single capillaries to be evaluated
morphologically
In the distal row, each single capillary of the capillaroscopic
images was marked with arrows by a novice (S.B.,
Ghent), who was trained by the supervisor (V.S.) (Fig. 1
and supplementary Fig. S1, available at Rheumatology
Online). This marking with arrows was double-checked by
the supervisor. In total, 319 capillaries were marked. As no
information on the prevalence of the three types of capil-
laries (normal, abnormal or not evaluable) in the general RD
microcirculation evaluable population was available, per
default estimations of prevalence were used to calculate
the number of single capillaries to be presented to the
raters. This resulted in a total of 90 randomly sampled
capillaries out of the pool of 319 capillaries being presented
to each rater (see Statistical methods). These 90 single
capillaries were presented in two batches of 45 capillaries
each. The reason for having two presentations was to
reduce the risk of observer fatigue from a longer single
presentation. To assess inter-rater reliability, the raters
read and scored all images once.
Presentation of simple morphological definitions
Simple morphological definitions were presented as
drawings in a PowerPoint slide with minimal verbal
descriptions (Fig. 2): Definition 0—normal or non-specific
(defined as hairpin, crossing or tortuous); Definition
1—abnormal (not hairpin, not tortuous and not crossing);
Definition 2—not evaluable (whenever rater undecided in
classifying between normal and abnormal) [3, 11]. Raters
were instructed not to assess dimension (apical diameter
of capillaries). Consequently, if a dimension was abnor-
mal, but the shape (morphology) was normal, the capil-
lary was to be assessed as normal. Fig. 1 gives examples
of nailfold videocapillaroscopy images. The gold
standard was set upon the judgement of one expert
rater, V.S.
Presentation of the capillaries to be evaluated by the
raters
The set of 90 single capillary morphologies to be evalu-
ated were presented in three settings to the different
groups of raters: independent experienced raters; at-
tendees of the sixth EULAR course on capillaroscopy,
Genova 2014; and novices after a 1-h course at
the Ghent University Hospital, November 2014. The pre-
viously mentioned definitions and instructions were
sent by instructional email to the expert raters (setting
1) and shown to the raters of settings 2 and 3 by
means of a PowerPoint slide during a lecture on
884 www.rheumatology.oxfordjournals.org
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capillaroscopic definitions. When evaluating a single
capillary morphology, the rater had to click one of the
three options from a web-based system (supplementary
Fig. S2, available at Rheumatology Online). This web-
based system was secure and custom-constructed.
The study was approved by the local ethics committee
(Ghent University Hospital, Belgium), and all subjects
participating in the study signed written informed
consent.
Statistical analysis and sample size
Based upon an aimed kappa of 0.80 and equal default
estimated prevalences, in the general RD microcirculatory
evaluable population, of normal (0.4) and abnormal (0.4)
capillary morphology and a smaller proportion of not eva-
luable (0.2) capillaries, 87 capillaries evaluated by two
raters were necessary to obtain a half width of the 95%
CI of no larger than 0.2 (80% power, 5% significance
level). Consequently, 90 randomly selected single capil-
laries (36 normal, 36 abnormal and 18 not evaluable)
were presented in two batches of 45 single capillaries to
the three groups of raters.
Inter-rater agreement of nominal data was assessed
by calculation of the proportion of agreement and by
kappa coefficients [mean kappa-values for each rater
vs gold standard (V.S.)]. Light’s kappa was also as-
sessed for the experienced raters by computing the
kappa for all coder pairs (V.S.A.L.H., V.S.F.I.,
V.S.V.R., V.S.A.S., A.H.F.I., A.L.H.F.R., A.L.H.A.S.,
F.I.V.R., F.I.A.S., V.R.A.S.) and then computing the
arithmetic mean [12]. Landis and Koch [13] guidelines
were used for interpreting kappa values, with values
from 0.0 to 0.2 indicating slight agreement, 0.21 to 0.40
indicating fair agreement, 0.41 to 0.60 indicating moder-
ate agreement, 0.61 to 0.80 indicating substantial agree-
ment and 0.81 to 1.0 indicating almost perfect or perfect
agreement. Two post hoc analyses were performed. In
the first one, two categories (normal or non-specific vs
abnormal or not evaluable) were taken into account in-
stead of three. The second post hoc analysis was per-
formed with capillaries assigned to either normal or
abnormal, while those that could not be classified were
excluded.
Overall and partial (abnormal, normal or non-specific,
not evaluable) proportions of agreement were calcu-
lated for the three groups of raters. Values are repre-
sented as mean percentages (over all raters). Statistical
analyses were performed using R version 3.1.2 (R
Foundation for Statistical Computing, 2011, Vienna,
Austria).
FIG. 1 Examples of nailfold videocapillaroscopy images, with marked individual capillaries
(A) is an example of a normal—hairpin capillary; (B) of a normal—tortuous capillary; (C) of a normal—crossing capillary;
(D) of an abnormal capillary. (For minimal verbal descriptions, see Fig. 2.).
www.rheumatology.oxfordjournals.org 885
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Results
Participants
Five experienced independent raters [A.L.H., F.I., V.R.,
A.S., V.S. (gold standard)], 34 attendees at the sixth
EULAR course on capillaroscopy (Genova 2014) and 11
novices after a 1-h course at the Ghent University hospital
(autumn 2014) participated in the study (see list of
collaborators).
Inter-rater repeatability
Mean kappa based on 90 capillaries was 0.47 (95% CI:
0.39, 0.54) for expert raters, 0.40 (95% CI: 0.36, 0.44) for
attendees and 0.46 (95% CI: 0.41, 0.52) for novices
(Table 1), with overall agreements of 67% (95% CI: 63,
71), 63% (95% CI: 60, 65) and 67% (95% CI: 63, 70),
respectively (Table 2). Light’s kappa for the expert raters
was 0.49 (95% CI: 0.44, 0.54). Comparing only normal vs
the combined groups of [AQ5]abnormal and not evaluable
capillaries did increase the kappa: 0.51 (95% CI: 0.37,
0.65), 0.53 (95% CI: 0.49, 0.58) and 0.55 (0.49, 0.62),
with a Light’s kappa for the experts of 0.53 (95% CI:
0.47, 0.60) (Table 3).
Evaluation of kappa of images, on the condition they
could be classified as performed elsewhere in literature
[14, 15], resulted in the following values: 0.62 (95% CI:
0.50, 0.74) for expert raters (evaluable only, n = 65), 0.76
(95% CI: 0.69, 0.83) for attendees (evaluable only, n = 20)
and 0.81 (95% CI: 0.74, 0.89) for novices (evaluable only,
n = 44) (supplementary Table S1, available at
Rheumatology Online).
Discussion
In order to facilitate interpretability of studies on microcir-
culation across RD, a standardisation of definitions on
morphology is paramount. To this end, the EULAR study
group on microcirculation in RD, established in June 2014,
conducted a pilot study of simple capillaroscopic morpho-
logical definitions. The key findings of this multicentre,
international study were the following: first, just after
seeing the simple definitions (normal, abnormal, not eva-
luable) in a PowerPoint presentation during a lecture on
capillaroscopy, attendees and novices had a moderate
reliability in evaluating individual capillaries [respectively,
mean kappa of 0.40 (95% CI: 0.36, 0.44) and 0.46 (95%
CI: 0.41, 0.52)]. Assessing their reliability, on the condition
FIG. 2 Information given to the raters concerning the definitions of normal and abnormal capillaries
Normal had been defined as hairpin shaped (drawing 1) or non-specific variation (drawing 2 or 3): tortuous (the limbs
bend but do not cross) or crossing (the limbs cross once or twice). Abnormal (drawing 4) had been defined as not 1, nor 2
or 3 [11, 16]. Of note, the raters had been asked not to assess the dimension of the capillaries in judging whether the
capillary had an abnormal morphology or not.






Expert raters after email instruction (n = 5) 0.47 (0.39, 0.54) 0.49 (0.44, 0.54)
Attendees of sixth EULAR course on capillaroscopy
after short oral instruction (n = 34)
0.40 (0.36, 0.44) NA
Novices after a 1-h institutional course (n = 11) 0.46 (0.41, 0.52) NA
NA: not applicable.
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they were able to classify the images (= extracting the not
evaluables from the analysis) augmented their reliability
[mean kappa of 0.76 (95% CI: 0.69, 0.83) and 0.81 (95%
CI: 0.74, 0.89)], but greatly diminished the number of
images being evaluated. Second, experts, who had only
received instructions via mail had a moderate reliability
[mean kappa of 0.47 (95% CI: 0.39, 0.54)]—in line with
the moderate reliability of the novices. This equal reliability
between experts and non-experts may simply be a matter
of training and instructions on the use of uniform defin-
itions. Further optimization based on consensus meetings
will be performed. Third, novices are capable of distin-
guishing normal from abnormal capillaries by means of a
1-h training session. Consequently, when encountering an
abnormal capillary, they may refer the patient to an expert
centre in nailfold videocapillaroscopy.
Looking at the capillaries where experts did not have
consistent evaluation of the individual morphology, Fig. 3
reveals that the proposed simple definitions still leave the
rater with difficulties when rating real-life capillaries. One
of the pitfalls might be the fact that experts, in judging a
single capillary, also took the characteristic dimension into
consideration, whereas in this study the raters were asked
only to judge morphology. In this way, consequently,
some of the experts had evaluated a giant capillary
(normal morphology but dimension of apical diam-
eter>50) as an abnormal capillary, even though the
shape (morphology) was normal. Consequently, further
instructional refinement of the simple definitions would
be a primary goal for future studies of the EULAR study
group on microcirculation. It will clearly need to be
stressed that only morphology (shape) is to be taken
into consideration and not the dimension. One way to
do this will be to speak of normal or abnormal shapes,
rather than of normal or abnormal capillaries. Of note, the
expert raters, even though from different European cen-
tres, all performed similarly in evaluating the individual ca-
pillary morphologies. This is attested by the fact that the
Light’s kappa (which is an arithmetic mean of all coder
pairs of experts) equals the plain kappa (which reflects
the concordance of each individual expert rater vs the
gold standard).
Fourth, grouping together the not evaluable with the
abnormal category renders a higher reliability, which
may suggest that in future studies the class not evaluable
may be obsolete. Since the partial agreement for the not
evaluable capillaries was manifest lower in comparison
with the two other groups, the definition of not evaluable
can be questioned. Due to the fact that the kappa in-
creases when taking the not evaluable capillaries together
with the abnormal capillaries, one could propose that,
whenever a rater is undecided in classifying a capillary
as normal or abnormal, he should select the abnormal
category. The definition of normal vs abnormal could be
biased due to adjacent capillaries in the image. The idea
was to provide the images as they would present them-
selves in a real-life setting. It is likely that when a normal
capillary is presented in a setting of loss of capillaries and
abnormal distribution, the rater would score the normal
capillary as abnormal.
In conclusion, this multicentre, international pilot study
has, first, demonstrated the moderate reliability of simple







Group of raters Abnormal Normal
Not
evaluable
Expert raters after email instruction (n = 5) 67 (63, 71) 69 (64, 74) 75 (70, 80) 32 (2, 62)
Attendees of sixth EULAR course on
capillaroscopy after short oral instruction(n = 34)
63 (60, 65) 64 (61, 67) 73 (71, 76) 24 (18, 30)
Novices after a 1-h institutional course (n = 11) 67 (63, 70) 71 (66, 76) 75 (72, 78) 26 (18, 35)






Expert raters after email instruction (n = 5) 0.51 (0.37, 0.65) 0.53 (0.47, 0.60)
Attendees of sixth EULAR course on
capillaroscopy after short oral instruction (n = 34)
0.53 (0.49, 0.58) NA
Novices after a 1-h institutional course (n = 11) 0.55 (0.49, 0.62) NA
Mean kappa (95% CI) for the three groups of raters and Light’s kappa (95% CI) for the expert raters [comparison between two
categories (normal vs the combined groups of abnormal and not evaluable) instead of three (normal vs abnormal vs not
evaluable)]. NA: not applicable.
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definitions for use in describing capillaroscopic morph-
ology by rheumatologists with varying levels of expertise
in the technique. Second, novices were found to be cap-
able of distinguishing normal from abnormal capillaries by
means of a 1-h training session. In future studies, the
class not evaluable may be obsolete.
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